| E-cadherin: Its dysregulation in carcinogenesis and clinical implications |
58 |
| The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper |
50 |
| A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors |
39 |
| Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer |
32 |
| Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review |
24 |
| Cancer cachexia: Diagnosis, assessment, and treatment |
24 |
| Systemic therapy in cervical cancer: 30 years in review |
23 |
| Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets |
22 |
| PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review |
22 |
| The unfolded protein response as a target for anticancer therapeutics |
22 |
| The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review |
21 |
| Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis |
21 |
| Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review |
20 |
| Immunotherapy in advanced gastric cancer, is it the future? |
20 |
| Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives |
19 |
| Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review |
19 |
| Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials |
18 |
| Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis |
17 |
| The TRAIL to cancer therapy: Hindrances and potential solutions |
17 |
| Current management of neuroblastoma and future direction |
16 |
| Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer; a systematic review and meta-analysis |
16 |
| Melatonin and breast cancer: Evidences from preclinical and human studies |
16 |
| RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment |
16 |
| Molecular targets of celastrol in cancer: Recent trends and advancements |
15 |
| Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
15 |
| Biomarkers of response to immune checkpoint blockade in cancer treatment |
15 |
| The microbiome and cancer for clinicians |
15 |
| Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials |
15 |
| Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives |
15 |
| Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions |
14 |
| Dietary total antioxidant capacity and risk of cancer: a systematic review and meta-analysis on observational studies |
14 |
| The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers |
14 |
| Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives |
14 |
| Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer |
13 |
| Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research |
13 |
| Hopes and failures in front-line ovarian cancer therapy |
13 |
| Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review |
13 |
| Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review |
13 |
| Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia |
13 |
| Crosstalk in cancer resistance and metastasis |
12 |
| Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection |
12 |
| An attempt to conceptualize the individual onto-functional balance: Why a standardized treatment is an illusion for diffuse low-grade glioma patients |
12 |
| Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables |
12 |
| Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy |
12 |
| Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results |
12 |
| Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or F-18-fluorodeoxyglucose positron emission tomography/CT (F-18-FDG PET/CT) in patients with myeloma: Systematic review of diagnostic performance |
12 |
| Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system |
12 |
| Management of adverse effects/toxicity of ibrutinib |
11 |
| Radioiodine refractory differentiated thyroid cancer |
11 |
| Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis |
11 |
